SCHEMBL6169802

SCHEMBL6169802

CC(C)C(C(=O)O)c1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 16/20 0.61
▸ CA1 P00915 4/20 0.61
▸ CA2 P00918 4/20 0.61
▸ MT-CO2 P00403 3/20 0.61
▸ CA12 O43570 3/20 0.61
▸ CA9 Q16790 3/20 0.61
▸ PTGS1 P23219 3/20 0.61
▸ CA4 P22748 2/20 0.61
▸ CA7 P43166 2/20 0.61
▸ LMNA P02545 1/20 0.61
▸ CA3 P07451 1/20 0.61
▸ ADRB2 P07550 1/20 0.61
▸ ADRB1 P08588 1/20 0.61
▸ CYP3A4 P08684 1/20 0.61
▸ ADORA3 P0DMS8 1/20 0.61
▸ CHRM1 P11229 1/20 0.61
▸ ADRA2B P18089 1/20 0.61
▸ CA6 P23280 1/20 0.61
▸ SLC6A2 P23975 1/20 0.61
▸ PDE4A P27815 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4884123 0.88 PTGS2 (0.64) PTGS2CA1CA2MT-CO2CA12
SCHEMBL8800861 0.88 PTGS2 (0.56) PTGS2CA1CA2MT-CO2CA12
SCHEMBL5983421 0.87 PTGS2 (0.68) PTGS2CA1CA2MT-CO2CA12
SCHEMBL4891512 0.86 PTGS2 (0.70) PTGS2CA1CA2MT-CO2CA12
SCHEMBL4809281 0.83 PTGS2 (0.70) PTGS2CA1CA2MT-CO2CA12
SCHEMBL6169647 0.83 PTGS2 (0.60) PTGS2CA1CA2MT-CO2CA12
SCHEMBL8475026 0.83 PTGS2 (0.60) PTGS2CA1CA2MT-CO2CA12
SCHEMBL8474584 0.82 PTGS2 (0.59) PTGS2CA1CA2MT-CO2CA12
SCHEMBL214781 0.81 PTGS2 (0.66) PTGS2CA1CA2MT-CO2CA12
SCHEMBL8477236 0.81 PTGS2 (0.60) PTGS2CA1CA2MT-CO2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 — — EP claimed
EP-0809636-B1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-09-04 — — EP claimed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 — — EP claimed
EP-0809636-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-12-03 — — EP claimed
WO-1996025405-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-22 — — WO claimed
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 — — EP disclosed
EP-0809636-B1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-09-04 — — EP disclosed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 — — EP disclosed
EP-0809636-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-12-03 — — EP disclosed
WO-1996025405-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-22 — — WO disclosed
Send feedback